1. Oluniyi PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, et al.
   HIV-1 drug resistance and genetic diversity in a cohort of people living with HIV-1 in Nigeria.
   AIDS 2021.
   


2. Ronald R, Gartland M, Li Z, Zhou N, et al.
   Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc.
   AIDS 2021.
   


3. Yan H, Peters H, Thorne C.
   Neonatal deaths among infants born to women living with HIV in the UK and Ireland 1998-2017.
   AIDS 2021.
   


4. Siddiqui J, Samuel SK, Hayward B, Wirka KA, et al.
   HIV-associated wasting prevalence in the era of modern antiretroviral therapy: a claims database study (2012-2018).
   AIDS 2021.
   


5. Eastment MC, Wanje G, Richardson BA, Mwaringa E, et al.
   Results of a cluster randomized trial testing the systems analysis and improvement approach to increase HIV testing in family planning clinics in Mombasa, Kenya.
   AIDS 2021.
   


6. Nichols BE, Rosen S.
   Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors' reply.
   AIDS 2021;35:2235-2236.
   


7. Claassen CW, Lindsay B, Riedel DJ, Kafunda I, et al.
   Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs.
   AIDS 2021;35:2234-2235.
   


8. Heil EL, Pandit NS, Taylor GH.
   Probable hepatotoxicity from two second-generation integrase strand transfer inhibitors.
   AIDS 2021;35:2232-2233.
   


9. Gener AR.
   Editorial commentary on 'the other side of screening: predictors of treatment and follow-up for anal precancers in a large health system'.
   AIDS 2021;35:2215-2216.
   


10. Cachay ER, Hadigan C, Mathews WC.
    Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevail.
    AIDS 2021;35:2211-2213.
    


11. Silveira ELV, Hong JJ, Amancha PK, Rogers KA, et al.
    Viremia controls Env-specific antibody-secreting cell responses in simian immunodeficiency virus infected macaques pre and post-antiretroviral therapy.
    AIDS 2021;35:2085-2094.
    


12. Dombrowski JC.
    Chlamydia and Gonorrhea.
    Ann Intern Med 2021.
    


13. Henderson HI, Napravnik S, Gower EW, Aiello AE, et al.
    Resistance in Enterobacterales is higher among people with HIV.
    Clin Infect Dis 2021.
    


14. Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, et al.
    Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19.
    Clin Infect Dis 2020.
    


15. Venter WDF, Nel J.
    COVID-19: First data from Africa.
    Clin Infect Dis 2020.
    


16. Boulle A, Davies MA, Hussey H, Ismail M, et al.
    Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.
    Clin Infect Dis 2020.
    


17. Huang J, Xie N, Hu X, Yan H, et al.
    Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study.
    Clin Infect Dis 2020.
    


18. Pyra M, Brewer R, Rusie L, Kline J, et al.
    Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.
    J Acquir Immune Defic Syndr 2021.
    


19. Longino AA, Paul R, Wang Y, Lama JR, et al.
    HIV disease dynamics, markers of inflammation and CNS injury during primary HIV infection and their relationship to cognitive performance.
    J Acquir Immune Defic Syndr 2021.
    


20. Kaplan SR, Escudero JN, Mecha J, Richardson BA, et al.
    Interferon gamma release-assay and tuberculin skin test performance in pregnant women living with and without HIV.
    J Acquir Immune Defic Syndr 2021.
    


21. Diaz RS, Grangeiro A, Estevam DL, Galinskas J, et al.
    Pre-exposure prophylaxis failure with a multiple drug-resistant HIV-1 clade C virus in Brazil.
    J Acquir Immune Defic Syndr 2021.
    


22. Fazeli PL, Woods SP, Lambert CC, Li W, et al.
    Differential Associations Between BDNF and Memory Across Older Black and White Adults with HIV Disease.
    J Acquir Immune Defic Syndr 2021.
    


23. Heller T, Wallrauch C, Gumulira J, Rambiki K, et al.
    Low CD4 counts despite effective ART in hospitalized Malawian HIV+/COVID+ co-infected patients.
    J Acquir Immune Defic Syndr 2021.
    


24. Matsuda EM, Ahagon CM, Coelho LPO, Campos IB, et al.
    A simple algorithm for selecting cases to investigate acute and early HIV infections in low- and middle-income countries.
    J Med Virol 2021.
    


25. Rahman S, Sarker MS, Aralaguppe SG, Sarwar G, et al.
    Drug resistance pattern among ART-naive clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    J Med Virol 2021.
    


26. Benner BE, Bruce JW, Kentala JR, Murray M, et al.
    Perturbing HIV-1 ribosomal frameshifting frequency reveals a cis preference for Gag-Pol incorporation into assembling virions.
    J Virol 2021.
    


27. Balamurugan A, Ng HL, Yang OO.
    Correction for Balamurugan et al., "Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones".
    J Virol 2021;95:e0139721.
    

Display articles in

• Abstract format
• Medline format